logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Rinat Neuroscience Corporation


USPTO Granted Patents = 53

% Expired Patents = 37.7



Forward Citations = 746

Loading Chart...
Loading Chart...

52 inventors (with patents filed for the assignee):

goldMedal Jaume Pons (24 out of 59 patents)

silverMedal David L Shelton (17 out of 44 patents)

bronzeMedal Arnon Rosenthal (16 out of 122 patents)

4.  Pavel Strop (15 out of 31 patents)

5.  Arvind Rajpal (14 out of 47 patents)

6.  Wei-Hsien Ho (12 out of 27 patents)

7.  Yasmina Noubia Abdiche (9 out of 25 patents)

8.  Javier Fernando Chaparro Riggers (8 out of 20 patents)

9.  Magdalena Grazyna Dorywalska (7 out of 8 patents)

10.  Weihsien Ho (5 out of 10 patents)

11.  Wenwu Zhai (5 out of 12 patents)

12.  Shu-Hui Liu (5 out of 16 patents)

13.  Bruce Charles Gomes (5 out of 6 patents)

14.  Hong Liang (5 out of 11 patents)

15.  Chia-Yang Lin (5 out of 30 patents)


Core Competencies:
Antibody-Drug Conjugates
Heterodimeric Proteins
Anti-PD-1 Antibodies
NGF Antagonists
Trop-2 Antibodies
Stability-Modulating Linkers
IL-7 Receptor Antibodies
PCSK9 Antagonists
Amyloid-Beta Peptide
TrkB Antagonists
Bone Cancer Treatment
Osteoarthritis Pain

53 patents:

1. 12624124 - HETERODIMERIC PROTEINS AND METHODS FOR PRODUCING AND PURIFYING THEM (2026-05-12),
2. 11602525 - Antibody-drug conjugates with high drug loading (2023-03-14),
3. 11390689 - Heterodimeric proteins and methods for producing and purifying them (2022-07-19),
4. 11338035 - Anti-PD-1 antibodies and methods of use thereof (2022-05-24),
5. 11198735 - Anti-GITR antibodies and methods of use thereof (2021-12-14),
6. 11091544 - Antibodies specific for Trop-2 and their uses (2021-08-17),
7. 11008386 - Anti-NGF antibodies and methods using same (2021-05-18),
8. 10967068 - Stability-modulating linkers for use with antibody drug conjugates (2021-04-06),
9. 10842881 - Engineered polypeptide conjugates using transglutaminase (2020-11-24),
10. 10825548 - Systems and methods of sensing and analyzing antibody blocking interactions (2020-11-03),
11. 10660953 - Anti-PD-1 antibodies and methods of use thereof (2020-05-26),
12. 10323086 - Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same (2019-06-18),
13. 10195289 - Engineered polypeptide conjugates using transglutaminase (2019-02-05),
14. 10155037 - Anti-PD-1 antibodies and methods of use thereof (2018-12-18),
15. 10138303 - Heterodimeric proteins and methods for producing and purifying them (2018-11-27),
Rinat Neuroscience Corporation, based in South San Francisco, CA, specializes in the development of innovative antibody therapeutics aimed at addressing various neurological conditions. The company focuses on advanced technologies such as antibody-drug conjugates and heterodimeric proteins, leveraging its expertise in anti-PD-1 antibodies and NGF antagonists. Rinat's research extends to stability-modulating linkers and IL-7 receptor antibodies, positioning it at the forefront of therapeutic solutions in the biopharmaceutical landscape.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

53 Patents

#28 in South San Francisco, CA

#1,566 in California

#6,664 in US

#13,323 in the World

South San Francisco, CA (US)
South San Francisco, CA, United States of America

Rinat Neuroscience Corporation

Forward Citations = 746

52 inventors:

goldMedal Jaume Pons (24 out of 59 patents)

silverMedal David L Shelton (17 out of 44 patents)

bronzeMedal Arnon Rosenthal (16 out of 122 patents)

4.  Pavel Strop (15 out of 31 patents)

5.  Arvind Rajpal (14 out of 47 patents)

Please report any incorrect information to [email protected]
Loading…